Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001850902-25-000014
Filing Date
2025-06-25
Accepted
2025-06-25 16:24:51
Documents
1
Period of Report
2025-02-14

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3831
  Complete submission text file 0001850902-25-000014.txt   5206
Mailing Address 2451 BERT DRIVE HOLLISTER CA 95023
Business Address 2451 BERT DRIVE HOLLISTER CA 95023 8316371100
Alpha Teknova, Inc. (Issuer) CIK: 0001850902 (see all company filings)

EIN.: 943368109 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 2290 BERT DRIVE HOLLISTER CA 95023
Business Address
Terrill Damon (Reporting) CIK: 0001859826 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40538 | Film No.: 251073914